Synthetic oxepanoprolinamide iboxamycin is active against <i>Listeria monocytogenes</i> despite the intrinsic resistance mediated by VgaL/Lmo0919 ABCF ATPase

Tetiana Brodiazhenko(University of Tartu), Vasili Hauryliuk(Lund University), Ben I.C. Tresco(Harvard University), Hiraku Takada(Kyoto Sangyo University), Kathryn Jane Turnbull(Rigshospitalet), Tanel Tenson(University of Tartu), Andrew G. Myers(Harvard University), Kelvin J. Y. Wu(Harvard University)
JAC-Antimicrobial Resistance
May 3, 2022
Cited by 10


Related Papers